Unknown

Dataset Information

0

CAR models: next-generation CAR modifications for enhanced T-cell function.


ABSTRACT: T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells as a therapy for B-cell malignancies being established, current and future research is being focused on adapting CAR technology to other cancers, as well as enhancing its efficacy and/or safety. The modular nature of the CAR, extracellular antigen-binding domain fused to a transmembrane domain and intracellular T-cell signaling domains, allows for optimization by replacement of the various components. These modifications are creating a whole new class of therapeutic CARs. In this review, we discuss the recent major advances in CAR design and how these modifications will impact its clinical application.

SUBMITTER: Abate-Daga D 

PROVIDER: S-EPMC4871190 | biostudies-other | 2016

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC9262817 | biostudies-literature
| S-EPMC7727537 | biostudies-literature
| S-EPMC7281723 | biostudies-literature
| S-EPMC10791545 | biostudies-literature
| S-EPMC7686910 | biostudies-literature
| S-EPMC6686900 | biostudies-literature
| S-EPMC8397867 | biostudies-literature
| S-EPMC6013407 | biostudies-literature
| S-EPMC7810492 | biostudies-literature
| S-EPMC7696189 | biostudies-literature